Deconinck N - Search Results

1

Two-year efficacy and safety of risdiplam in patients with type 2 or non-ambulant type 3 spinal muscular atrophy (SMA).

Oskoui M, Day JW, Deconinck N, Mazzone ES, Nascimento A, Saito K, Vuillerot C, Baranello G, Goemans N, Kirschner J, Kostera-Pruszczyk A, Servais L, Papp G, Gorni K, Kletzl H, Martin C, McIver T, Scalco RS, Staunton H, Yeung WY, Fontoura P, Mercuri E; SUNFISH Working Group. Oskoui M, et al. Among authors: deconinck n. J Neurol. 2023 May;270(5):2531-2546. doi: 10.1007/s00415-023-11560-1. Epub 2023 Feb 3. J Neurol. 2023. PMID: 36735057 Free PMC article. Clinical Trial.

2

Preserved coupling between the reader's voice and the listener's cortical activity in autism spectrum disorders.

Clumeck C, Suarez Garcia S, Bourguignon M, Wens V, Op de Beeck M, Marty B, Deconinck N, Soncarrieu MV, Goldman S, Jousmäki V, Van Bogaert P, De Tiège X. Clumeck C, et al. Among authors: deconinck n. PLoS One. 2014 Mar 24;9(3):e92329. doi: 10.1371/journal.pone.0092329. eCollection 2014. PLoS One. 2014. PMID: 24663673 Free PMC article.

3

Critical illness myopathy unrelated to corticosteroids or neuromuscular blocking agents.

Deconinck N, Van Parijs V, Beckers-Bleukx G, Van den Bergh P. Deconinck N, et al. Neuromuscul Disord. 1998 May;8(3-4):186-92. doi: 10.1016/s0960-8966(98)00003-0. Neuromuscul Disord. 1998. PMID: 9631400

4

Effect of muscle denervation on the expression of substance P in the ventral raphe-spinal pathway of the rat.

Van den Bergh P, De Beukelaer M, Deconinck N. Van den Bergh P, et al. Among authors: deconinck n. Brain Res. 1996 Jan 29;707(2):206-12. doi: 10.1016/0006-8993(95)01236-2. Brain Res. 1996. PMID: 8919297

5

Expression of truncated utrophin improves pH recovery in exercising muscles of dystrophic mdx mice: a 31P NMR study.

Goudemant JF, Deconinck N, Tinsley JM, Demeure R, Robert A, Davies KE, Gillis JM. Goudemant JF, et al. Among authors: deconinck n. Neuromuscul Disord. 1998 Aug;8(6):371-9. doi: 10.1016/s0960-8966(98)00049-2. Neuromuscul Disord. 1998. PMID: 9713853

6

Expression of truncated utrophin leads to major functional improvements in dystrophin-deficient muscles of mice.

Deconinck N, Tinsley J, De Backer F, Fisher R, Kahn D, Phelps S, Davies K, Gillis JM. Deconinck N, et al. Nat Med. 1997 Nov;3(11):1216-21. doi: 10.1038/nm1197-1216. Nat Med. 1997. PMID: 9359695

7

Functional protection of dystrophic mouse (mdx) muscles after adenovirus-mediated transfer of a dystrophin minigene.

Deconinck N, Ragot T, Maréchal G, Perricaudet M, Gillis JM. Deconinck N, et al. Proc Natl Acad Sci U S A. 1996 Apr 16;93(8):3570-4. doi: 10.1073/pnas.93.8.3570. Proc Natl Acad Sci U S A. 1996. PMID: 8622977 Free PMC article.

8

COG5-CDG: expanding the clinical spectrum.

Rymen D, Keldermans L, Race V, Régal L, Deconinck N, Dionisi-Vici C, Fung CW, Sturiale L, Rosnoblet C, Foulquier F, Matthijs G, Jaeken J. Rymen D, et al. Among authors: deconinck n. Orphanet J Rare Dis. 2012 Dec 10;7:94. doi: 10.1186/1750-1172-7-94. Orphanet J Rare Dis. 2012. PMID: 23228021 Free PMC article.

9

Polymicrogyria with dysmorphic basal ganglia? Think tubulin!

Amrom D, Tanyalçin I, Verhelst H, Deconinck N, Brouhard GJ, Décarie JC, Vanderhasselt T, Das S, Hamdan FF, Lissens W, Michaud JL, Jansen AC. Amrom D, et al. Among authors: deconinck n. Clin Genet. 2014 Feb;85(2):178-83. doi: 10.1111/cge.12141. Epub 2013 Apr 24. Clin Genet. 2014. PMID: 23495813

10

The physiological evaluation of gene therapies of dystrophin-deficient muscles.

Gillis JM, Deconinck N. Gillis JM, et al. Among authors: deconinck n. Adv Exp Med Biol. 1998;453:411-6; discussion 417. doi: 10.1007/978-1-4684-6039-1_45. Adv Exp Med Biol. 1998. PMID: 9889852 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

99 results

Search Page